Literature DB >> 15467003

On the nature of proteinuria with acute renal injury in patients with chronic kidney disease.

Rajiv Agarwal1.   

Abstract

Albuminuria is an excellent marker of cardiovascular and renal prognosis. Commercially available tests of immunodetectable albumin in the urine may not identify posttranslationally modified albumin that makes it undetectable to antibodies. Also, it is unclear whether albumin is degraded to smaller fragments, such as through proteolysis, in the course of acute renal injury. In 20 men with chronic kidney disease, we measured excretion rates of urinary protein (pyragallol red), immundetectable urinary albumin (immunoturbidimetry), and urinary total intact albumin (HPLC) after a single dose of 100 mg intravenous iron sucrose administered over 5 min. Fragmentation of urinary albumin and carbonylation of urinary proteins were assessed by immunoblotting. Results showed that iron infusion increased carbonylation of plasma and urinary proteins in a time-dependent manner. A transient increase in urinary excretion rates of total protein, immunodetectable urinary albumin, and total intact albumin was seen. Fragmentation and loss of immunoreactivity of albumin paralleled the changes in total protein excretion. In conclusion, fragmentation, loss of immunoreactivity, and oxidation of albumin in a time-dependent manner may underestimate the extent of injury with the immunoreactive microalbumin assay. Measurement of total intact albumin may better quantify acute renal injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467003     DOI: 10.1152/ajprenal.00318.2004

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

1.  Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial.

Authors:  Rajiv Agarwal; David J Leehey; Scott M Olsen; Naomi V Dahl
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

Review 2.  Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD.

Authors:  Peter Van Buren; Ruben L Velez; Nosratola D Vaziri; Xin J Zhou
Journal:  Int Urol Nephrol       Date:  2011-07-10       Impact factor: 2.370

3.  Relationship between albuminuria and total proteinuria in systemic lupus erythematosus nephritis: diagnostic and therapeutic implications.

Authors:  Daniel J Birmingham; Brad H Rovin; Ganesh Shidham; Michael Bissell; Haikady N Nagaraja; Lee A Hebert
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-01       Impact factor: 8.237

4.  Iron, oxidative stress, and clinical outcomes.

Authors:  Rajiv Agarwal
Journal:  Pediatr Nephrol       Date:  2007-11-21       Impact factor: 3.714

5.  Renal function in patients with non-dialysis chronic kidney disease receiving intravenous ferric carboxymaltose: an analysis of the randomized FIND-CKD trial.

Authors:  Iain C Macdougall; Andreas H Bock; Fernando Carrera; Kai-Uwe Eckardt; Carlo Gaillard; David Van Wyck; Yvonne Meier; Sylvain Larroque; Simon D Roger
Journal:  BMC Nephrol       Date:  2017-01-17       Impact factor: 2.388

6.  Oxidative damage to urinary proteins from the GRMD dog and mdx mouse as biomarkers of dystropathology in Duchenne muscular dystrophy.

Authors:  Jessica R Terrill; Basma A Al-Mshhdani; Marisa N Duong; Catherine D Wingate; Zahra Abbas; Angelo P Baustista; Amanda K Bettis; Cynthia J Balog-Alvarez; Joe N Kornegay; Peter P Nghiem; Miranda D Grounds; Peter G Arthur
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

Review 7.  Proteinuria in COVID-19.

Authors:  Muner M B Mohamed; Juan Carlos Q Velez
Journal:  Clin Kidney J       Date:  2021-03-26

8.  Serum magnesium levels in patients with diabetic retinopathy.

Authors:  Dipankar Kundu; Manish Osta; Tridibeswar Mandal; Ujjwal Bandyopadhyay; Debes Ray; Divyendu Gautam
Journal:  J Nat Sci Biol Med       Date:  2013-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.